Cargando…
The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol
BACKGROUND: Patients with bronchiectasis typically suffer from chronic symptoms such as a productive cough with or without exacerbations leading to hospitalization, causing reduced quality of life (QoL) and mortality. Long-term inhaled antibiotics to treat chronic bronchial infection is registered f...
Autores principales: | Terpstra, L.C., Altenburg, J., Bronsveld, I., Doodeman, H.J., Rozemeijer, W., Heijerman, H.G.M., Boersma, W.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747573/ https://www.ncbi.nlm.nih.gov/pubmed/36531900 http://dx.doi.org/10.1016/j.conctc.2022.101045 |
Ejemplares similares
-
Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis
por: Terpstra, Lotte C., et al.
Publicado: (2022) -
Treatment with inhaled antibiotics in bronchiectasis, side effects, and evaluation of the tolerance test; analysis from the BATTLE randomized controlled trial
por: Terpstra, Lotte C., et al.
Publicado: (2023) -
The effect of azithromycin on sputum inflammatory markers in bronchiectasis
por: Terpstra, L. C., et al.
Publicado: (2023) -
Evidence of Inhaled Tobramycin in Non-Cystic Fibrosis Bronchiectasis
por: Vendrell, Montserrat, et al.
Publicado: (2015) -
Pity ’Tis ’Tis True
Publicado: (1889)